|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
520 White Plains Road, Second Floor, Tarrytown, New York 10591, US
|
|
At Sapience, we think boldly about the possibilities for treating cancer. We aim to discover and develop peptide therapeutics to address oncogenic and immunogenic dysregulation that drive cancer. Our pipeline of SPEARs™ (Stabilized Peptides Engineered Against Regulation) disrupt intracellular protein-protein interactions, enabling targeting of transcription factors which have traditionally been considered undruggable. We are advancing our lead programs, ST316, a first-in-class antagonist of β-catenin, and ST101, a first-in-class antagonist of C/EBPβ, through Phase 1-2 clinical trials. Please engage with us on this platform to learn more!
|
Sapience Therapeutics, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Sapience Therapeutics, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Sapience Therapeutics, Inc. customer service number in your country click here to find.
Barry Kappel is the CEO of Sapience Therapeutics, Inc.. To contact Barry Kappel email at [email protected]. Or you may call 9146076931
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.